SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001510964-21-000052
Filing Date
2021-07-30
Accepted
2021-07-30 16:35:35
Documents
13
Period of Report
2021-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20210726.htm   iXBRL 8-K 34334
2 EX-10.1 grasseremploymentagreement.htm EX-10.1 37518
  Complete submission text file 0001510964-21-000052.txt   204223

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20210726.xsd EX-101.SCH 1933
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20210726_lab.xml EX-101.LAB 21488
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20210726_pre.xml EX-101.PRE 11112
6 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20210726_htm.xml XML 9080
Mailing Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121
Business Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 211133108
SIC: 2834 Pharmaceutical Preparations